Module

Advances in Hepatology: 2005

Source: Hepatitis Annual Update 2005

Advances in Hepatology: 2005


CME Program Director: Patrick J. Lynch, MD

Faculty:

  • Willis C. Maddrey, MD

CME CREDIT INFORMATION

Release Date: 10/13/05

Expiration Date: 10/12/06


Physicians: maximum of 1.0 AMA PRA Category 1 Credit(s)™

Pharmacists: 1 contact hour (0.1 CEUs)

Registered Nurses: 1 Nursing CE credit

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Describe the role that apoptosis plays in hepatic injury and the various mechanisms involved

  • Discuss the etiology of cholesterol gallstone disease and the mechanisms involved

  • Discuss the present and future state of select hepatology research


Content includes:

  • Hepatitis B
  • Hepatitis C
  • Apoptosis
  • Assessment of Fibrosis
  • Stellate Cells
  • Cholesterol and Gallstones
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Northwestern University’s Feinberg School of Medicine and Clinical Care Options, LLC.

Pharmacist and nursing credit provided through the cosponsorship of Medical Education Collaborative and Clinical Care Options, LLC.

Educational grants provided by:

Educational grants support only the CME-certified components of this program.